tion in mice, of H5N1 influenza A virus isolates from humans in Hong Kong.
J. Virol. 73:3184–3189.
Gubareva, L. V., J. A. McCullers, R. C. Bethell, and R. G. Webster. 1998.
Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse
model and protective effect of zanamavir on H5N1 infection in mice. J. In-fect. Dis. 178:1592–1596.
Haff, R. F., P. W. Schriver, C. G. Engle, and R. C. Stewart. 1966. Pathogenesis of influenza in ferrets. I. Tissue and blood manifestations of disease.
J. Immunol. 96:659–667.
Hatta, M., P. Gao, P. Halfmann, and Y. Kawaoka. 2001. Molecular basis for
high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840–
1842.
Hinshaw, V. S., R. G. Webster, B. C. Easterday, and W. J. Bean, Jr. 1981.
Replication of avian influenza A viruses in mammals. Infect. Immun. 34:
354–361.
Jakeman, K. J., H. Smith, and C. Sweet. 1989. Mechanism of immunity to
influenza: maternal and passive neonatal protection following immunization
of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins.
J. Gen. Virol. 70:1523–1531.
Katz, J. M., X. Lu, T. M. Tumpey, C. B. Smith, M. W. Shaw, and K.
Subbarao. 2000. Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74:10807–10810.
Leigh, M. W., R. J. Connor, S. Kelm, L. G. Baum, and J. C. Paulson. 1995.
Receptor specificity of influenza virus influences severity of illness in ferrets.
Vaccine 13:1468–1473.
Li, S., C. Liu, A. Klimov, K. Subbarao, M. L. Perdue, D. Mo, Y. Ji, L. Woods,
S. Hietala, and M. Bryant. 1999. Recombinant influenza A virus vaccines for
the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179:
1132–1138.
Li, S., M. Orlich, and R. Rott. 1990. Generation of seal influenza virus
variants pathogenic for chickens because of hemagglutinin cleavage site
changes. J. Virol. 64:3297–3303.
Lu, X., T. M. Tumpey, T. Morken, S. R. Zaki, N. J. Cox, and J. M. Katz. 1999.
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) virses isolated from humans. J. Virol. 73:5903–5911.
Maassab, H. F. 1969. Biologic and immunologic characteristics of coldadapted influenza virus. J. Immunol. 102:728–732.
Maassab, H. F., A. P. Kendal, G. D. Abrams, and A. S. Monto. 1982.
Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J. Infect.
Dis. 146:780–790.
Marois, P., A. Boudreault, E. DiFranco, and V. Pavilanis. 1971. Response of
ferrets and monkeys to intranasal infection with human, equine and avian
influenza viruses. Can. J. Comp. Med. 35:71–76.
Matrosovich, M., N. Zhou, Y. Kawaoka, and R. Webster. 1999. The surface
glycoproteins of H5 influenza viruses isolated from humans, chickens, and
wild aquatic birds have distinguishable properties. J. Virol. 73:1146–1155.
Murphy, B. R., D. L. Sly, N. T. Hosier, W. T. London, and R. M. Chanock.
1980. Evaluation of three strains of influenza A virus in humans, and in owl,
cebus and squirrel monkeys. Infect. Immun. 28:688–691.
Murphy, B. R., V. S. Hinshaw, D. L. Sly, W. T. London, N. T. Hosier, F. T.
Wood, R. G. Webster, and R. M. Chanock. 1982. Virulence of avian influenza
A viruses for squirrel monkeys. Infect. Immun. 37:1119–1126.
Nishimura, H., S. Itamura, T. Iwasaki, T. Kurata, and M. Tashiro. 2000.
Characterization of human influenza A (H5N1) virus infection in mice:
neuro-, pneumo- and adipotropic infection. J. Gen. Virol. 81:2503–2510.
Perkins, L. E. L., and D. E. Swayne. 2001. Pathobiology of A/Chicken/Hong
Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Vet.
Pathol. 38:149–164.
Potter, C. W., J. S. Oxford, S. L. Shore, C. McLaren, and C. Stuart-Harris.
1972. Immunity to influenza in ferrets. I. Response to live and killed virus.
Br. J. Exp. Pathol. 53:153–167.
Potter, C. W., S. L. Shore, C. McLaren, and C. Stuart-Harris. 1972. Immunity to influenza in ferrets. II. Influence of adjuvants on immunization. Br. J.
Exp. Pathol. 53:168–179.
Reed, L. J., and H. Muench. 1938. A simple method for estimating fifty
percent endpoints. Am. J. Hyg. 27:493–497.
Renegar, K. B. 1992. Influenza virus infections and immunity: a review of
human and animal models. Lab. Anim. Sci. 42:222–232.
Reuman, P. D., S. Keely, and G. M. Schiff. 1989. Assessment of signs of
influenza illness in the ferret model. J. Virol. Methods 24:27–34.
Rimmelzwaan, G. F., T. Kuiken, G. van Amerongen, T. M. Bestebroer,
R. A. M. Fouchier, and A. D. M. E. Osterhaus. 2001. Pathogenesis of
influenza A (H5N1) virus infection in a primate model. J. Virol. 75:6687–
6691.
Rowe, T. 2000. Biocontainment of highly pathogenic avian influenza viruses,
p. 16–34. In J. Richmond (ed.), Anthology of biosafety, vol. II. Facility design
considerations. American Biological Safety Association, Mundelein, Ill.
Scheiblauer, H., A. P. Kendal, and R. Rott. 1995. Pathogenicity of influenza
A/Seal/Mass/1/80 virus mutants for mammalian species. Arch. Virol. 140:
341–348.
Senne, D. A., B. Panigrapy, Y. Kawaoka, J. E. Pearson, J. Suss, M. Lipkind,
